← Leaderboards
Monica M Jablonski
University Of Tennessee Health Sci Ctr
$8,426,014
Attributed
$9,247,993
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,247,993 · 4
By mechanism
R24$5,339,037 · 1
R01$3,156,944 · 1
R03$421,139 · 1
P30$330,873 · 1
Top collaborators
- Lu Lu5 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Hao Chen$8,407,311
- Megan Kathleen Mulligan$3,609,287
- Lu Lu$8,163,944
- Ming D Li$15,975,608
- Burt M Sharp$10,107,182
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPhysiologic Intraocular PressureGlaucomaBlindnessOptic NerveResearch PersonnelGeneticLeadPositioning AttributeRetinaRetinal Ganglion CellsNovel TherapeuticsPathway InteractionsRisk FactorsLinkVisual FieldsTreatment StrategyCell DeathCessation Of LifeHaplotypesCorneaEndophenotypeInvestigationLaboratories
Grant awards (21)
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$905,799
R24 · FY2024 · EY · contact PI
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$938,961
R24 · FY2023 · EY · contact PI
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$927,111
R24 · FY2022 · EY · contact PI
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$397,797
R24 · FY2022 · EY · contact PI
Genetic Modulators of Glaucoma$371,798
R01 · FY2022 · EY · contact PI
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$1,031,691
R24 · FY2021 · EY · contact PI
Genetic Modulators of Glaucoma$371,486
R01 · FY2021 · EY · contact PI
Novel Extended Release Glaucoma Therapy for Once Daily Dosing$1,137,678
R24 · FY2020 · EY · contact PI
Genetic Modulators of Glaucoma$378,431
R01 · FY2020 · EY · contact PI
Genetic Modulators of Glaucoma$391,271
R01 · FY2019 · EY · contact PI
Genetic Modulation of Glaucoma$367,500
R01 · FY2014 · EY · contact PI
Genetic Modulation of Glaucoma$171,561
R01 · FY2014 · EY · contact PI
Genetic Modulation of Glaucoma$356,250
R01 · FY2013 · EY · contact PI
Genetic Modulation of Glaucoma$374,897
R01 · FY2012 · EY · contact PI
Genetic Modulation of Glaucoma$373,750
R01 · FY2011 · EY · contact PI
Proteomic Analysis of the Retina$141,770
R03 · FY2007 · EY · contact PI
Proteomic Analysis of the Retina$142,569
R03 · FY2006 · EY · contact PI
Proteomic Analysis of the Retina$136,800
R03 · FY2005 · EY
CORE--CELL BIOLOGY$110,291
P30 · FY2002 · EY
CORE--CELL BIOLOGY$110,291
P30 · FY2001 · EY
CORE--CELL BIOLOGY$110,291
P30 · FY2000 · EY